Stock screener

DNA

Conviction 64HealthcareScan · Thu, Sep 24, 2026

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.28 (+19.81%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 72, RS Rating 44, -36.3% from its 52-week high, +18.2% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

DNA$10.28+19.81%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.53M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +100.00%· 2 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Ginkgo Bioworks Holdings, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.ginkgobioworks.com ↗
Price10.28
Change+19.81%
Gap-0.58%
Rel volume2.44×
Avg volume1.43M
Avg $ vol11.29M
SMA 207.46
SMA 507.61
SMA 2008.25
Price vs 50+35.10%
Price vs 200+24.57%
MA stackmixed
50/200 cross—
Supertrendup · 7.17
RSI (14)72
MACD hist0.35
MACD cross—
Stoch %K / %D96 / 82
ADX (14)26
+DI / −DI42 / 7
RSI divergence—
MACD divergenceBullish
ATR %6.85%
ADR %7.06%
52w high16.14
52w low5.48
From 52w high-36.31%
Above 52w low+87.59%
New 52w highNo
SqueezeOff
Bollinger width50.05%
%B1.26
Donchian pos95.67%
Donchian high10.45
Donchian low6.52
AVWAP (52w high)8.89
vs AVWAP high+15.63%
AVWAP (52w low)8.27
vs AVWAP low+24.34%
OBV trendUp
Chaikin MF (20)0.22
Today vs 20d2.44×
Avg vol (14d)1.53M
Avg vol (20d)1.43M
Avg $ vol (20d)11.29M
Market cap654.95M
RS Rating44 / 99
RS 3m (vs SPY)+2.93%
RS 6m (vs SPY)+22.86%
RS line new highNo
Trend template4/8
Technical rank96.1
1 week+31.12%
1 month+36.34%
3 months+7.42%
6 months+39.67%
1 year-16.76%
YTD+18.16%
P/E-2.09
P/B1.56
P/S3.85
P/FCF-3.66
EPS-5.64
Div yield—
ROE-74.42%
ROA-31.59%
Debt/Eq—
Current4.57
EV/EBITDA-2.23
Gross margin—
Net margin-183.81%
Rev growth-25.06%
EPS growth42.83%
Price target7.00
Target upside-31.91%
Analyst ratingSell
Institutional70.74%
Ent. value570.42M
Revenue20.16M
Net income-46.71M
Gross profit—
Free cash flow-178.72M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNYSE
Shares out53.36M
Employees485
ListedMon, Apr 19, 2021
Free float40.26M
Float %80.6%
Short interest6.87M
Days to cover5.5d
Short volume60.4%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.86
Last surprise—
Setup gradeB
Conviction64 / 100
Pattern quality—
Tech rank96.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.90
Support6.50
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DNA

All disclosures →
No recent disclosed trades by Congress in DNA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DNA · open-market 2 sells

InsiderSideShares
Coen Steven P.
See remarks · Class A Common Stock · 2026-08-24
Sell330
Coen Steven P.
See remarks · Restricted Stock Units · 2026-08-21
Exercise587
Coen Steven P.
See remarks · Class A Common Stock · 2026-08-21
Exercise587
Coen Steven P.
See remarks · Restricted Stock Units · 2026-08-21
Exercise156
Coen Steven P.
See remarks · Class A Common Stock · 2026-08-21
Exercise156
Coen Steven P.
See remarks · Class A Common Stock · 2026-05-22
Sell307
Coen Steven P.
See remarks · Class A Common Stock · 2026-05-21
Exercise587
Coen Steven P.
See remarks · Restricted Stock Units · 2026-05-21
Exercise587
Coen Steven P.
See remarks · Restricted Stock Units · 2026-05-21
Exercise156
Coen Steven P.
See remarks · Class A Common Stock · 2026-05-21
Exercise156

SEC filings

EDGAR filings in DNA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.